Risk FactorsSexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalLibidoErectile DysfunctionOrgasmSexualityPenile ErectionDyspareuniaEjaculationSexual BehaviorSex CounselingQuestionnairesUrination DisordersPrevalenceGonadal HormonesNeurodermatitisEroticaPremature EjaculationCoitusHyperprolactinemiaThiazidesHypogonadismPenisVentricular Dysfunction, LeftSexologyQuality of LifeCase-Control StudiesPersonal SatisfactionCross-Sectional StudiesSerotonin Uptake InhibitorsProspective StudiesSyriaAntipsychotic AgentsWomen's HealthPenile ImplantationVaginal DiseasesAge FactorsPhosphodiesterase 5 InhibitorsFollow-Up StudiesTreatment OutcomeAndropauseIncidenceLogistic ModelsCohort StudiesTestosteroneTime FactorsDepressionRetrospective StudiesUrinary IncontinenceSex FactorsRisk AssessmentPhosphodiesterase InhibitorsProstatismParoxetineMultivariate AnalysisSulfonesCardiovascular DiseasesSurvivorsMarriagePhotoplethysmographyCyclic Nucleotide Phosphodiesterases, Type 5Pituitary HormonesAnxietyDiabetes ComplicationsNigeriaComorbidityArousalPurinesAntidepressive Agents, Second-GenerationFluoxetineSouth AmericaPelvisSexual Behavior, AnimalAge DistributionSocioeconomic FactorsPostoperative ComplicationsHealth StatusCystitis, InterstitialIranEpidemiologic MethodsBrazilSmokingChi-Square DistributionSex DistributionRenal DialysisOdds RatioHypertensionHormone Replacement TherapyRectal NeoplasmsKidney Failure, ChronicProstatectomyVentricular DysfunctionDepressive DisorderAntidepressive AgentsSpinal Cord InjuriesPiperazinesHealth SurveysEndothelium, VascularDopamine Agonists